KeyBank National Association
CABA icon

KeyBank National Association’s Cabaletta Bio CABA Stock Holding History

KeyBank National Association’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,506
Closed -$102K – 1159
2024
Q3 		$102K Hold
21,506
– – ﹤0.01% 1120
2024
Q2 		$161K Buy
21,506
+5,612
+35% +$68.8K ﹤0.01% 1067
2024
Q1 		$271K Buy
+15,894
New +$341K ﹤0.01% 959

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KeyBank National Association's CABA Position: Q4 2024 in Review

KeyBank National Association sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 21,506 shares — an estimated $102K sold.

KeyBank National Association first reported a position in CABA in Q1 2024 and held it in 3 quarters. The position peaked at $271K in Q1 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.

  • KeyBank National Association reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
  • KeyBank National Association sold 21,506 Cabaletta Bio shares in Q4 2024, an estimated $102K.
  • KeyBank National Association first reported a position in Cabaletta Bio in Q1 2024 and held it in 3 quarters.
  • KeyBank National Association's Cabaletta Bio position peaked at $271K in Q1 2024.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.

Based on KeyBank National Association's 13F filing for Q4 2024, filed 6 Feb 2025.